ClinicalTrials.Veeva

Menu

What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE

R

Rennes University Hospital

Status

Completed

Conditions

Oocyte Donation
Pregnancy

Treatments

Other: preeclampsia

Study type

Observational

Funder types

Other

Identifiers

NCT03668184
35RC17_3078_PREROVE

Details and patient eligibility

About

The main goal is to determine which risk factors develop preeclampsia in this specific group of oocyte recipients.

Enrollment

150 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All major patients with a pregnancy of more than 22 weeks of amenorrhea resulting from an oocyte donation in one of the study centers, having given birth between January 2010 and April 2017 and not opposed to participation in the study.

Exclusion criteria

  • all pregnancies resulting from an oocyte donation abroad, persons of legal age subject to legal protection (safeguard of justice, guardianship, tutorship) and persons deprived of their liberty.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems